|
|
|||
|
||||
OverviewThis issue of ""Gastroenterology Clinics of North America"" is on Gastrointestinal Motility Disorders. GI motility disorders are common reasons for patients to see gastroenterologists. Knowledge of the pathophysiology, evaluation and treatment of these disorders is important to appropriately care for patients with gastrointestinal motility disorders in clinical practice. The chapters of this issue will discuss key aspects of gastrointestinal motility disorders focusing on how they relate to practicing gastroenterologists and other health care providers. Current knowledge in the area as well as evolving concepts from clinical investigations and translational research from basic sciences will be discussed. The rapid explosion of new technology used in the evaluation of patients will be covered. Full Product DetailsAuthor: Henry ParkmanPublisher: Elsevier - Health Sciences Division Imprint: Saunders Volume: v. 36-3 Dimensions: Width: 16.00cm , Height: 1.90cm , Length: 23.20cm Weight: 0.617kg ISBN: 9781416050728ISBN 10: 1416050728 Pages: 288 Publication Date: 01 September 2007 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Out of Print Availability: Out of stock Table of ContentsReviewsAuthor InformationDr. Parkman has been actively involved in studying GI motility at Temple University School of Medicine at the basic science and clinical levels. His clinical focus has been treating patients with GI motility disorders. Clinically, Dr. Parkman oversees the GI Motility Laboratory. His clinical laboratory has developed expertise in a comprehensive array of GI motility tests for clinical evaluation of patients. Dr. Parkman was funded for 10 years with an NIH K24 Midcareer Investigator Award in Patient-Oriented Research where he mentored young investigators in clinical research. Dr. Parkman is currently a funded member of the NIH Gastroparesis Clinical Research Consortium. During his presidency of the American Neurogastroenterological and Motility Society, Dr. Parkman helped standardize the radionuclide gastric emptying study resulting in a standardized test. He remains active with an initiative to develop a patient-reported outcome (PRO) for gastroparesis that meets the approval of the Food and Drug Administration (FDA). Tab Content 6Author Website:Countries AvailableAll regions |
||||